{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:49:07Z","timestamp":1790488147831,"version":"4.1.0"},"reference-count":159,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2020.01062","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T04:17:04Z","timestamp":1590639424000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Novel Treatments of Adult T Cell Leukemia Lymphoma"],"prefix":"10.3389","volume":"11","author":[{"given":"Hiba","family":"El Hajj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Tsukasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Cheminant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bazarbachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-019-0504-z","article-title":"Molecular epidemiology, genetic variability and evolution of HTLV-1 with special emphasis on African genotypes.","volume":"16","author":"Afonso","year":"2019","journal-title":"Retrovirology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1182\/blood-2010-02-270751","article-title":"Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors.","volume":"116","author":"Afonso","year":"2010","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1182\/blood-2008-04-154286","article-title":"Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation.","volume":"112","author":"Arnold","year":"2008","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.4049\/jimmunol.163.7.4064","article-title":"Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2\/15R beta receptor.","volume":"163","author":"Azimi","year":"1999","journal-title":"J. Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S1470-2045(19)30320-1","article-title":"IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial.","volume":"20","author":"Bagot","year":"2019","journal-title":"Lancet Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4940","DOI":"10.1073\/pnas.91.11.4940","article-title":"The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.","volume":"91","author":"Bamford","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1128\/JVI.01513-06","article-title":"Proinflammatory cytokine gene induction by human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 Tax in primary human glial cells.","volume":"81","author":"Banerjee","year":"2007","journal-title":"J. Virol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev-immunol-042617-053222","article-title":"Human T cell leukemia virus type 1: persistence and pathogenesis.","volume":"36","author":"Bangham","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1182\/blood-2017-06-792382","article-title":"KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting.","volume":"130","author":"Battistella","year":"2017","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1158\/0008-5472.can-03-2390","article-title":"Human T-cell lymphotropic virus type I-infected cells extravasate through the endothelial barrier by a local angiogenesis-like mechanism.","volume":"64","author":"Bazarbachi","year":"","journal-title":"Cancer Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/bmt.2014.143","article-title":"Outcome of patients with HTLV-1-associated adult T-cell leukemia\/lymphoma after SCT: a retrospective study by the EBMT LWP.","volume":"49","author":"Bazarbachi","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"B12","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood.V93.1.278","article-title":"Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells.","volume":"93","author":"Bazarbachi","year":"1999","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1470-2045(04)01608-0","article-title":"New therapeutic approaches for adult T-cell leukaemia.","volume":"5","author":"Bazarbachi","year":"","journal-title":"Lancet Oncol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1097\/00042560-199600001-00028","article-title":"Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia\/lymphoma patients.","volume":"13","author":"Bazarbachi","year":"1996","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"B15","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","article-title":"Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes.","volume":"28","author":"Bazarbachi","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1182\/blood-2011-03-345702","article-title":"How I treat adult T-cell leukemia\/lymphoma.","volume":"118","author":"Bazarbachi","year":"2011","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.clim.2014.09.012","article-title":"Safety, efficacy, and pharmacokinetics\/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia\/lymphoma.","volume":"155","author":"Berkowitz","year":"2014","journal-title":"Clin. Immunol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.12469.2","article-title":"Single-cell heterogeneity and cell-cycle-related viral gene bursts in the human leukaemia virus HTLV-1.","volume":"2","author":"Billman","year":"2017","journal-title":"Wellcome Open Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1309\/2YGD1P0QCVCWBLDX","article-title":"Adult T-cell leukemia\/lymphoma in Bahia, Brazil: analysis of prognostic factors in a group of 70 patients.","volume":"128","author":"Bittencourt","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"key":"B20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood.V62.2.401.401","article-title":"The human T-cell leukemia\/lymphoma virus associated with American adult T-cell leukemia\/lymphoma.","volume":"62","author":"Blayney","year":"1983","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood.V100.5.1715.h81702001715_1715_1720","article-title":"Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab.","volume":"100","author":"Buggins","year":"2002","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJM198308043090501","article-title":"Clinical course of retrovirus-associated adult T-cell lymphoma in the United States.","volume":"309","author":"Bunn","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ddtec.2019.02.004","article-title":"Cereblon modulators: low molecular weight inducers of protein degradation.","volume":"31","author":"Chamberlain","year":"2019","journal-title":"Drug Discov. Today Technol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1182\/blood-2008-04-149658","article-title":"Effective treatment of a murine model of adult T-cell leukemia using depsipeptide and its combination with unmodified daclizumab directed toward CD25.","volume":"113","author":"Chen","year":"2009","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/j.1349-7006.2012.02373.x","article-title":"Increase in incidence of adult T-cell leukemia\/lymphoma in non-endemic areas of Japan and the United States.","volume":"103","author":"Chihara","year":"2012","journal-title":"Cancer Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1200\/JCO.18.00501","article-title":"Revised adult T-cell leukemia-lymphoma international consensus meeting report.","volume":"37","author":"Cook","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1517\/14656566.2011.571207","article-title":"Newer developments in adult T-cell leukemia\/lymphoma therapeutics.","volume":"12","author":"Dasanu","year":"2011","journal-title":"Expert Opin. Pharmacother."},{"key":"B28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1182\/blood-2014-04-572750","article-title":"ATL response to arsenic\/interferon therapy is triggered by SUMO\/PML\/RNF4-dependent Tax degradation.","volume":"125","author":"Dassouki","year":"2015","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/bjc.1991.423","article-title":"Deoxycoformycin in the treatment of mature T-cell leukaemias.","volume":"64","author":"Dearden","year":"1991","journal-title":"Br. J. Cancer"},{"key":"B30","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1084\/jem.20101095","article-title":"Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia.","volume":"207","author":"El Hajj","year":"2010","journal-title":"J. Exp. Med."},{"key":"B31","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1182\/blood.V99.9.3383","article-title":"Human T-cell lymphotropic virus type 1-transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells.","volume":"99","author":"El-Sabban","year":"2002","journal-title":"Blood"},{"key":"B32","first-page":"2849","article-title":"Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation.","volume":"96","author":"El-Sabban","year":"2000","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1182\/blood-2015-08-662593","article-title":"Polycomb-dependent epigenetic landscape in adult T-cell leukemia.","volume":"127","author":"Fujikawa","year":"2016","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-018-0122-2","article-title":"Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential.","volume":"6","author":"Gan","year":"2018","journal-title":"Biomark Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"12813","DOI":"10.1128\/jvi.76.24.12813-12822.2002","article-title":"The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription.","volume":"76","author":"Gaudray","year":"2002","journal-title":"J. Virol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s13149-011-0174-4","article-title":"[Human retrovirus HTLV-1: descriptive and molecular epidemiology, origin, evolution, diagnosis and associated diseases].","volume":"104","author":"Gessain","year":"2011","journal-title":"Bull. Soc. Pathol. Exot."},{"key":"B37","first-page":"163","article-title":"[Epidemiology, origin and genetic diversity of HTLV-1 retrovirus and STLV-1 simian affiliated retrovirus].","volume":"93","author":"Gessain","year":"2000","journal-title":"Bull. Soc. Pathol. Exot."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","article-title":"Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine.","volume":"332","author":"Gill","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"22911","DOI":"10.1074\/jbc.274.33.22911","article-title":"IKKgamma serves as a docking subunit of the IkappaB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein.","volume":"274","author":"Harhaj","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B40","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nm1389","article-title":"Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I.","volume":"12","author":"Hasegawa","year":"2006","journal-title":"Nat. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/leu.2010.315","article-title":"LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia\/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway.","volume":"25","author":"Hasegawa","year":"2011","journal-title":"Leukemia"},{"key":"B42","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/sj.thj.6200195","article-title":"A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia\/lymphoma.","volume":"3","author":"Hermine","year":"2002","journal-title":"Hematol. J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","article-title":"Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa.","volume":"332","author":"Hermine","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/sj.thj.6200374","article-title":"Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed\/refractory adult T-cell leukemia\/lymphoma.","volume":"5","author":"Hermine","year":"2004","journal-title":"Hematol. J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s12325-018-0658-4","article-title":"A review of new findings in adult T-cell leukemia-lymphoma: a focus on current and emerging treatment strategies.","volume":"35","author":"Hermine","year":"2018","journal-title":"Adv. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2165\/00063030-199810060-00003","article-title":"Adult T cell leukaemia: a review of established and new treatments.","volume":"10","author":"Hermine","year":"1998","journal-title":"Biodrugs"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","article-title":"Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study.","volume":"116","author":"Hishizawa","year":"2010","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-018-0415-4","article-title":"The HTLV-1 oncoprotein Tax is modified by the ubiquitin related modifier 1 (Urm1).","volume":"15","author":"Hleihel","year":"2018","journal-title":"Retrovirology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1200\/JCO.2011.35.5578","article-title":"Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia\/lymphoma.","volume":"29","author":"Hodson","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.","volume":"393","author":"Horwitz","year":"2019","journal-title":"Lancet"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/j.bbmt.2019.05.027","article-title":"Efficacy of allogeneic hematopoietic cell transplantation in human T cell lymphotropic virus type 1-associated adult T cell leukemia\/lymphoma: results of a systematic review\/meta-analysis.","volume":"25","author":"Iqbal","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1200\/JCO.2016.67.7732","article-title":"Multicenter phase II study of lenalidomide in relapsed or recurrent adult T-cell leukemia\/lymphoma: ATLL-002.","volume":"34","author":"Ishida","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/bjh.13338","article-title":"Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.","volume":"169","author":"Ishida","year":"2015","journal-title":"Br. J. Haematol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study.","volume":"30","author":"Ishida","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/j.1349-7006.2006.00307.x","article-title":"CCR4 as a novel molecular target for immunotherapy of cancer.","volume":"97","author":"Ishida","year":"2006","journal-title":"Cancer Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-09-2697","article-title":"Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia\/lymphoma.","volume":"16","author":"Ishii","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","article-title":"Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma.","volume":"15","author":"Ishitsuka","year":"2014","journal-title":"Lancet Oncol."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1807852","article-title":"PD-1 Inhibitor Therapy in Adult T-Cell Leukemia-Lymphoma.","volume":"379","author":"Ishitsuka","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12185-016-2073-4","article-title":"Cereblon and its downstream substrates as molecular targets of immunomodulatory drugs.","volume":"104","author":"Ito","year":"2016","journal-title":"Int. J. Hematol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/cas.13948","article-title":"Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: a hope for disease-preventive therapy.","volume":"110","author":"Kannagi","year":"","journal-title":"Cancer Sci."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-019-0484-z","article-title":"Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.","volume":"16","author":"Kannagi","year":"","journal-title":"Retrovirology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature18294","article-title":"Aberrant PD-L1 expression through 3\u2019-UTR disruption in multiple cancers.","volume":"534","author":"Kataoka","year":"2016","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","article-title":"Treatment and survival among 1594 patients with ATL.","volume":"126","author":"Katsuya","year":"2015","journal-title":"Blood"},{"key":"B64","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1182\/blood-2009-03-211821","article-title":"Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia\/lymphoma (ATL).","volume":"113","author":"Kchour","year":"2009","journal-title":"Blood"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1038\/sj.onc.1210804","article-title":"Ubiquitylated Tax targets and binds the IKK signalosome at the centrosome.","volume":"27","author":"Kfoury","year":"2008","journal-title":"Oncogene"},{"key":"B66","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.cdd.4401624","article-title":"Proapoptotic regimes for HTLV-I-transformed cells: targeting Tax and the NF-kappaB pathway.","volume":"12","author":"Kfoury","year":"2005","journal-title":"Cell Death Differ."},{"key":"B67","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/B978-0-12-394280-7.00003-8","article-title":"The multifaceted oncoprotein Tax: subcellular localization, posttranslational modifications, and NF-kappaB activation.","volume":"113","author":"Kfoury","year":"2012","journal-title":"Adv. Cancer Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1182\/blood-2010-05-285742","article-title":"Tax ubiquitylation and SUMOylation control the dynamic shuttling of Tax and NEMO between Ubc9 nuclear bodies and the centrosome.","volume":"117","author":"Kfoury","year":"2011","journal-title":"Blood"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-10-52","article-title":"Interferon-alpha (IFN-alpha) suppresses HTLV-1 gene expression and cell cycling, while IFN-alpha combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells.","volume":"10","author":"Kinpara","year":"2013","journal-title":"Retrovirology"},{"key":"B70","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/1097-0142(19870315)59:6<1187::AID-CNCR2820590626>3.0.CO;2-8","article-title":"Hypercalcemia and osteoclast proliferation in adult T-cell leukemia.","volume":"59","author":"Kiyokawa","year":"1987","journal-title":"Cancer"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-2-36","article-title":"Mechanism of action of lenalidomide in hematological malignancies.","volume":"2","author":"Kotla","year":"2009","journal-title":"J. Hematol. Oncol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1423-0410.2008.01136.x","article-title":"Blood safety strategies for human T-cell lymphotropic virus in Europe.","volume":"96","author":"Laperche","year":"2009","journal-title":"Vox Sang"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1634\/theoncologist.2017-0524","article-title":"Recent Advances in the Treatment of Peripheral T-Cell Lymphoma.","volume":"23","author":"Laribi","year":"2018","journal-title":"Oncologist"},{"key":"B74","doi-asserted-by":"publisher","first-page":"104664","DOI":"10.18632\/oncotarget.22272","article-title":"Advances in the understanding and management of T-cell prolymphocytic leukemia.","volume":"8","author":"Laribi","year":"2017","journal-title":"Oncotarget"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/0006-291x(89)92322-x","article-title":"Human T-cell leukemia virus minus strand transcription in infected T-cells.","volume":"163","author":"Larocca","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC inhibitors in cancer development and therapy.","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/leu.2013.288","article-title":"EZH2 in normal and malignant hematopoiesis.","volume":"28","author":"Lund","year":"2014","journal-title":"Leukemia"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-016-0249-x","article-title":"Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis.","volume":"13","author":"Ma","year":"2016","journal-title":"Retrovirology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1182\/bloodadvances.2016001370","article-title":"Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-alpha.","volume":"1","author":"Macchi","year":"2017","journal-title":"Blood Adv."},{"key":"B80","doi-asserted-by":"crossref","first-page":"E1269","DOI":"10.1073\/pnas.1715724115","article-title":"Sporadic on\/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells.","volume":"115","author":"Mahgoub","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1182\/blood-2015-06-652040","article-title":"A vaccine against HTLV-1 HBZ makes sense.","volume":"126","author":"Mahieux","year":"2015","journal-title":"Blood"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1080\/14712598.2017.1347634","article-title":"Mogamulizumab for the treatment of T-cell lymphoma.","volume":"17","author":"Makita","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"key":"B83","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/bloodadvances.2017011106","article-title":"Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States.","volume":"2","author":"Malpica","year":"2018","journal-title":"Blood Adv."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-020-0513-y","article-title":"Arsenic trioxide (As2O3) as a maintenance therapy for adult T cell leukemia\/lymphoma.","volume":"17","author":"Marcais","year":"2020","journal-title":"Retrovirology"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-6-71","article-title":"The HBZ gene, a key player in HTLV-1 pathogenesis.","volume":"6","author":"Matsuoka","year":"2009","journal-title":"Retrovirology"},{"key":"B86","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/onc.2010.537","article-title":"Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.","volume":"30","author":"Matsuoka","year":"2011","journal-title":"Oncogene"},{"key":"B87","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2141.2001.02794.x","article-title":"Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients.","volume":"113","author":"Matutes","year":"2001","journal-title":"Br. J. Haematol."},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00558","article-title":"Mouse models that enhanced our understanding of adult T cell leukemia.","volume":"9","author":"Moodad","year":"2018","journal-title":"Front. Microbiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1128\/jvi.78.9.4582-4590.2004","article-title":"Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.","volume":"78","author":"Mori","year":"2004","journal-title":"J. Virol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1128\/JVI.75.2.1083-1089.2001","article-title":"Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus).","volume":"75","author":"Mortreux","year":"2001","journal-title":"J. Virol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1182\/blood-2003-07-2440","article-title":"A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients.","volume":"103","author":"Moura","year":"2004","journal-title":"Blood"},{"key":"B92","doi-asserted-by":"crossref","first-page":"8852","DOI":"10.1128\/JVI.72.11.8852-8860.1998","article-title":"Human T-cell lymphotropic\/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB\/ATF functional domain.","volume":"72","author":"Mulloy","year":"1998","journal-title":"J. Virol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1111\/cas.13655","article-title":"Oncogenic roles of enhancer of zeste homolog 1\/2 in hematological malignancies.","volume":"109","author":"Nakagawa","year":"2018","journal-title":"Cancer Sci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1182\/blood-2005-09-3572","article-title":"Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-kappaB activation.","volume":"107","author":"Nasr","year":"2006","journal-title":"Blood"},{"key":"B95","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1182\/blood-2002-09-2986","article-title":"Arsenic\/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells.","volume":"101","author":"Nasr","year":"2003","journal-title":"Blood"},{"key":"B96","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1158\/1078-0432.CCR-14-0830","article-title":"Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive\/refractory mycosis fungoides and Sezary syndrome.","volume":"21","author":"Ni","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.leukres.2007.05.026","article-title":"Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor kappaB.","volume":"32","author":"Nishioka","year":"2008","journal-title":"Leuk. Res."},{"key":"B98","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/j.1365-2141.2007.06704.x","article-title":"Killer cell immunoglobulin-like receptor\/3DL2 expression in adult T-cell leukaemia.","volume":"138","author":"Obama","year":"2007","journal-title":"Br. J. Haematol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1016\/S2352-3026(15)00284-7","article-title":"Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study.","volume":"3","author":"Ogura","year":"2016","journal-title":"Lancet Haematol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nm0507-527","article-title":"The Tax protein of HTLV-1 promotes oncogenesis in not only immature T cells but also mature T cells.","volume":"13","author":"Ohsugi","year":"2007","journal-title":"Nat. Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.lrr.2019.04.001","article-title":"Effective maintenance treatment with lenalidomide for a patient with aggressive adult T cell leukemia after chemotherapy.","volume":"11","author":"Oka","year":"2019","journal-title":"Leuk. Res. Rep."},{"key":"B102","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1200\/JCO.2006.10.2434","article-title":"Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.","volume":"25","author":"Olsen","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1128\/JVI.03113-15","article-title":"Functional comparison of HBZ and the related APH-2 protein provides insight into human T-cell leukemia virus type 1 pathogenesis.","volume":"90","author":"Panfil","year":"2016","journal-title":"J. Virol."},{"key":"B104","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/294268a0","article-title":"Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukaemia.","volume":"294","author":"Poiesz","year":"1981","journal-title":"Nature"},{"key":"B105","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/(SICI)1097-0215(19991029)83:3<291::AID-IJC1>3.0.CO;2-P","article-title":"Geographic diversity of adult t-cell leukemia\/lymphoma in Brazil. The Brazilian ATLL Study Group.","volume":"83","author":"Pombo De Oliveira","year":"1999","journal-title":"Int. J. Cancer"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.v98.4.1200","article-title":"The contribution of NF-kappa B activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors.","volume":"98","author":"Portis","year":"2001","journal-title":"Blood"},{"key":"B107","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s11912-011-0186-8","article-title":"Newly emerging therapies targeting viral-related lymphomas.","volume":"13","author":"Ramos","year":"2011","journal-title":"Curr. Oncol. Rep."},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004420","article-title":"Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma.","volume":"4","author":"Ratner","year":"2009","journal-title":"PLoS One"},{"key":"B109","first-page":"696","article-title":"PD-1 inhibitor therapy in adult T-cell leukemia-lymphoma.","volume":"379","author":"Ratner","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1056\/NEJMc1803181","article-title":"Rapid progression of adult T-cell leukemia-lymphoma after PD-1 inhibitor therapy.","volume":"378","author":"Ratner","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-6-19","article-title":"In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP).","volume":"6","author":"Saito","year":"2009","journal-title":"Retrovirology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1073\/pnas.0507631103","article-title":"HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells.","volume":"103","author":"Satou","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B113","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1158\/1078-0432.CCR-16-1022","article-title":"Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1-Associated Adult T-cell Leukemia\/lymphoma.","volume":"23","author":"Sharma","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"B114","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br. J. Haematol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1074\/jbc.M210665200","article-title":"The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity.","volume":"278","author":"Shinkawa","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B116","doi-asserted-by":"publisher","first-page":"8092","DOI":"10.1128\/JVI.00918-15","article-title":"A transgenic drosophila melanogaster model to study human T-lymphotropic virus oncoprotein tax-1-driven transformation in vivo.","volume":"89","author":"Shirinian","year":"2015","journal-title":"J. Virol."},{"key":"B117","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood.V73.6.1664.1664","article-title":"Profiles of expression of activated cell antigens on peripheral blood and lymph node cells from different clinical stages of adult T-cell leukemia.","volume":"73","author":"Shirono","year":"1989","journal-title":"Blood"},{"key":"B118","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/10428194.2019.1672052","article-title":"Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies.","volume":"61","author":"Siddiqi","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.2165\/11631090-000000000-00000","article-title":"Mogamulizumab: first global approval.","volume":"72","author":"Subramaniam","year":"2012","journal-title":"Drugs"},{"key":"B120","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/bjh.13302","article-title":"Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia\/lymphoma in a pilot study.","volume":"169","author":"Suehiro","year":"2015","journal-title":"Br. J. Haematol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1182\/blood-2015-04-641118","article-title":"Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor.","volume":"126","author":"Sugata","year":"2015","journal-title":"Blood"},{"key":"B122","doi-asserted-by":"publisher","first-page":"17945","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans.","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B123","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/00042560-199606010-00012","article-title":"An intensive chemotherapy of adult T-cell leukemia\/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support.","volume":"12","author":"Taguchi","year":"1996","journal-title":"J. Acquir Immune Defic. Syndr. Hum. Retrovirol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1182\/blood-2009-09-242347","article-title":"Long-term study of indolent adult T-cell leukemia-lymphoma.","volume":"115","author":"Takasaki","year":"2010","journal-title":"Blood"},{"key":"B125","first-page":"416","article-title":"[Surface markers of malignant lymphoid cells in the classification of lymphoproliferative disorders, with special reference to adult T-cell leukemia (author\u2019s transl)].","volume":"17","author":"Takatsuki","year":"1976","journal-title":"Rinsho Ketsueki"},{"key":"B126","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/ijc.2910370303","article-title":"Clinical analysis of 33 patients with adult T-cell leukemia (ATL)-diagnostic criteria and significance of high- and low-risk ATL.","volume":"37","author":"Tamura","year":"1986","journal-title":"Int. J. Cancer"},{"key":"B127","first-page":"4903","article-title":"Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives.","volume":"51","author":"Tanabe","year":"1991","journal-title":"Cancer Res."},{"key":"B128","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1349-7006.2010.01833.x","article-title":"Leukemic T cells are specifically enriched in a unique CD3(dim) CD7(low) subpopulation of CD4(+) T cells in acute-type adult T-cell leukemia.","volume":"102","author":"Tian","year":"2011","journal-title":"Cancer Sci."},{"key":"B129","first-page":"1250","article-title":"Current management of adult T-cell leukemia\/lymphoma.","volume":"23","author":"Tobinai","year":"2009","journal-title":"Oncology"},{"key":"B130","first-page":"164","article-title":"Phase I study of YK-176 (2\u2032-deoxycoformycin) in patients with adult T-cell leukemia-lymphoma. The DCF study group.","volume":"22","author":"Tobinai","year":"1992","journal-title":"Jpn. J. Clin. Oncol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11899-012-0124-3","article-title":"Targeting chemokine receptor CCR4 in adult T-cell leukemia-lymphoma and other T-cell lymphomas.","volume":"7","author":"Tobinai","year":"2012","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"B132","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/bjc.1994.394","article-title":"Treatment of adult T-cell leukaemia-lymphoma with irinotecan hydrochloride (CPT-11), CPT-11 Study Group on Hematological Malignancy.","volume":"70","author":"Tsuda","year":"1994","journal-title":"Br. J. Cancer"},{"key":"B133","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting.","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/bf02983215","article-title":"Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109).","volume":"77","author":"Tsukasaki","year":"2003","journal-title":"Int. J. Hematol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"B136","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.canlet.2016.12.022","article-title":"Whole body clonality analysis in an aggressive STLV-1 associated leukemia (ATLL) reveals an unexpected clonal complexity.","volume":"389","author":"Turpin","year":"2017","journal-title":"Cancer Lett."},{"key":"B137","first-page":"150","article-title":"Cell surface phenotype and in vitro function of adult T-cell leukemia cells.","volume":"1","author":"Uchiyama","year":"1983","journal-title":"Diagn. Immunol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1440-1827.1979.tb03176.x","article-title":"Adult T-cell leukemia with generalized cytomegalic inclusion disease and pneumocystis carinii pneumonia.","volume":"29","author":"Ueda","year":"1979","journal-title":"Acta Pathol. Jpn."},{"key":"B139","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","article-title":"Human T-lymphotropic virus 1: recent knowledge about an ancient infection.","volume":"7","author":"Verdonck","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1172\/JCI111379","article-title":"Functional and phenotypic comparison of human T cell leukemia\/lymphoma virus positive adult T cell leukemia with human T cell leukemia\/lymphoma virus negative Sezary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.","volume":"73","author":"Waldmann","year":"1984","journal-title":"J. Clin. Invest."},{"key":"B141","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V86.11.4063.bloodjournal86114063","article-title":"Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.","volume":"86","author":"Waldmann","year":"1995","journal-title":"Blood"},{"key":"B142","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1182\/blood.V82.6.1701.1701","article-title":"The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia.","volume":"82","author":"Waldmann","year":"1993","journal-title":"Blood"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005584","article-title":"HTLV-1 Tax Functions as a Ubiquitin E3 Ligase for Direct IKK Activation via Synthesis of Mixed-Linkage Polyubiquitin Chains.","volume":"12","author":"Wang","year":"2016","journal-title":"PLoS Pathog."},{"key":"B144","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nature24649","article-title":"PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis.","volume":"552","author":"Wartewig","year":"2017","journal-title":"Nature"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1182\/blood-2016-09-692574","article-title":"Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells.","volume":"129","author":"Watanabe","year":"2017","journal-title":"Blood"},{"key":"B146","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1128\/JVI.69.5.2863-2868.1995","article-title":"Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy.","volume":"69","author":"Wattel","year":"1995","journal-title":"J. Virol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/10428190109057927","article-title":"The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia\/lymphoma.","volume":"40","author":"White","year":"2001","journal-title":"Leuk. Lymphoma"},{"key":"B148","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1200\/JCO.2010.28.9066","article-title":"Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma.","volume":"28","author":"Whittaker","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","article-title":"A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.","volume":"113","author":"Yamada","year":"2001","journal-title":"Br. J. Haematol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/j.celrep.2019.10.083","article-title":"Targeting excessive EZH1 and EZH2 activities for abnormal histone methylation and transcription network in malignant lymphomas.","volume":"29","author":"Yamagishi","year":"2019","journal-title":"Cell Rep."},{"key":"B151","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ccr.2011.12.015","article-title":"Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers.","volume":"21","author":"Yamagishi","year":"2012","journal-title":"Cancer Cell"},{"key":"B152","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2222\/jsv.62.9","article-title":"[miRNA in HTLV-1 related disease].","volume":"62","author":"Yamagishi","year":"2012","journal-title":"Uirusu"},{"key":"B153","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V62.4.758.758","article-title":"A proposal for smoldering adult T-cell leukemia: a clinicopathologic study of five cases.","volume":"62","author":"Yamaguchi","year":"1983","journal-title":"Blood"},{"key":"B154","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/s0092-8674(00)81466-x","article-title":"Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation.","volume":"93","author":"Yamaoka","year":"1998","journal-title":"Cell"},{"key":"B155","doi-asserted-by":"publisher","first-page":"9359","DOI":"10.1128\/JVI.00242-08","article-title":"Transcriptional control of spliced and unspliced human T-cell leukemia virus type 1 bZIP factor (HBZ) gene.","volume":"82","author":"Yoshida","year":"2008","journal-title":"J. Virol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/leu.2014.241","article-title":"Augmented efficacy with the combination of blockade of the Notch-1 pathway, bortezomib and romidepsin in a murine MT-1 adult T-cell leukemia model.","volume":"29","author":"Yu","year":"2015","journal-title":"Leukemia"},{"key":"B157","doi-asserted-by":"publisher","first-page":"424","DOI":"10.7150\/ijms.30154","article-title":"Histone Deacetylases (HDACs) Guided Novel Therapies for T-cell lymphomas.","volume":"16","author":"Zhang","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00247","article-title":"HBZ and its roles in HTLV-1 oncogenesis.","volume":"3","author":"Zhao","year":"2012","journal-title":"Front. Microbiol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.leukres.2011.07.015","article-title":"Efficacy of novel histone deacetylase inhibitor, AR42, in a mouse model of, human T-lymphotropic virus type 1 adult T cell lymphoma.","volume":"35","author":"Zimmerman","year":"2011","journal-title":"Leuk. Res."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.01062\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T16:04:39Z","timestamp":1696176279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.01062\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":159,"alternative-id":["10.3389\/fmicb.2020.01062"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.01062","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,28]]},"article-number":"1062"}}